| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |